PORTANOVA, Patrizia
PORTANOVA, Patrizia
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway.
2006-01-01 GIULIANO, M; CALVARUSO, G; PELLERITO, O; PORTANOVA, P; CARLISI, D; VENTO, R; TESORIERE, G
APOPTOTIC EFFECTS INDUCED BY ANANDAMIDE IN HEPATIC CELLS.
2005-01-01 GIULIANO M; CALVARUSO G; PELLERITO O; PORTANOVA P; VENTO R; TESORIERE G
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8.
2006-01-01 CALVARUSO G; GIULIANO M; PORTANOVA P; DE BLASIO A; VENTO R; TESORIERE G
COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO IN COLTURA
2009-01-01 Pellerito, O; Portanova, P; Notaro, A; Calvaruso, G; Giuliano, M; Tesoriere, G
Complessi di Organostagno(IV) con amminoacidi e dipeptidi: sintesi, caratterizzazione e attività biologica in vitro.
2008-01-01 RUBINO, S; GIRASOLO, MA; PORTANOVA, P; STOCCO, GC
COMPLESSI POLINUCLEARI DI Pt(II)CON LEGANTI POLIPIRIDINICI. SINTESI, CARATTERIZZAZIONE STRUTTURALE E SPETTROSCOPICA, ATTIVITÀ CITOTOSSICA
2006-01-01 RUBINO S; PORTANOVA P; CALVARUSO G; ALBANESE A; FONTANA G; ORECCHIO S; STOCCO G
Degradation of IkBalfa during apoptosis induced by proteasome inhibitors in hepatoma cells.
2004-01-01 PORTANOVA P; PELLERITO O; GIULIANO M; CALVARUSO G; VENTO R; TESORIERE G
Electrophoretic Mobility Shift Assay (EMSA) or Gel Shift Assay
2008-01-01 Portanova, P; Augello, G; Calvaruso, G
Hsp-72 contrasta l'effetto apoptotico indotto dal bortezomib in cellule di epatoblastoma umano Hep-G2
2006-01-01 PORTANOVA P; PELLERITO O; GIULIANO M; CALVARUSO G; VENTO R; TESORIERE G
Hsp72 and NF-κB protect human hepatoma HepG2 cells in the first phase of treatment with bortezomib
2006-01-01 PORTANOVA P; GIULIANO M; CALVARUSO G
Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors.
2007-01-01 CALVARUSO, G; GIULIANO, M; PORTANOVA, P; PELLERITO, O; VENTO, R; TESORIERE, G
JNK AND AP-1 MEDIATE APOPTOSIS INDUCED BY BORTEZOMIB IN HEPATOMA HEPG2 CELLS.
2005-01-01 LAURICELLA M; EMANUELE S; D'ANNEO A; VASSALLO B; CARLISI D; PORTANOVA P; CALVARUSO G; VENTO R; TESORIERE G
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways
2006-01-01 LAURICELLA M; EMANUELE S; D'ANNEO A; CALVARUSO G; VASSALLO B; CARLISI D; PORTANOVA P; VENTO R; TESORIERE G
MONO- AND POLYNUCLEAR COMPLEXES OF PT(II) WITH POLYPYRIDYL LIGANDS SYNTHESIS, SPECTROSCOPIC AND STRUCTURAL CHARACTERIZATION AND CYTOTOXIC ACTIVITY
2007-01-01 RUBINO S; PORTANOVA P; ALBANESE A; CALVARUSO G; ORECCHIO S; FONTANA G; STOCCO GC
New organotin(IV) complexes with L-Arginine,Nα-t-Boc-L-Arginine and L-Alanyl-L-Arginine.Synthesis, structural investigations and cytotoxic activity
2010-01-01 Girasolo, MA; Rubino, S; Portanova, P; Calvaruso, G; Ruisi, G; Stocco, G
Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
2013-01-01 Portanova, P; Notaro, A; Pellerito, O; Sabella, S; Giuliano, M; Calvaruso, G
Nuove tecniche di dosaggio: la Cloned Enzyme Donor Immuno Assay (CEDIA)
2004-01-01 PORTANOVA P; VOCCA L; GUGLIEMINI E; BIVONA G; MACAIONE V; MICCICHE' S; CIACCIO M
Nuove tecniche di dosaggio: la Cloned Enzyme Donor Immuno Assay (CEDIA)
2004-01-01 PORTANOVA P; VOCCA L; GUGLIELMINI E; BIVONA G; MACAIONE V; MICCICHE' S; CIACCIO M
p8 (candidate of metasiasis 1) drives ER-stress/autophagy/apoptosis axis induced by the synthetic cannabinoid WIN in HCC cells.
2010-01-01 Pellerito, O; Portanova, P; Notaro, A; Marotta,D; Calvaruso, G; Giuliano,M.
Polynuclear complexes of Pt(II) with polypyridyl ligands.II.Synthesis, spectroscopic and structural characterization and cytotoxic activity
2007-01-01 RUBINO S; PORTANOVA P; GIRASOLO M A; CALVARUSO G; ORECCHIO S; STOCCO G